Bromadol BDPC, the newly synthetic analgesic, exhibits unique biological properties. It mostly operates by a partial mu-opioid binding site agonist, however demonstrates considerable influence on the kappa binding site and well. This combined action produces to the complex set of impacts, including analgesia, sedation, and possibly breathing red